PDF(Pubmed)
Abstract：
Mycobacterium szulgai is a slow-growing nontuberculous mycobacterium (NTM). It was first described in 1972 and is responsible for less than 0.2% of all NTM infections. The most common presentation resembles pulmonary tuberculosis, but it may also present as an extrapulmonary disease. It primarily affects individuals with underlying lung disease or immunocompromising conditions. The increasing use of tumor necrosis factor-alpha inhibitors, such as adalimumab, is associated with an increased risk of serious infections. We report a case of Mycobacterium szulgai infection in a 23-year-old woman with a history of childhood pneumonia and Crohn\'s disease on adalimumab.
摘要：
szulgai分枝杆菌是一种生长缓慢的非结核分枝杆菌（NTM）。它于1972年首次描述，占所有NTM感染的不到0.2％。最常见的表现类似于肺结核，但它也可能表现为肺外疾病。它主要影响患有潜在肺部疾病或免疫受损状况的个体。越来越多地使用肿瘤坏死因子-α抑制剂，比如阿达木单抗，与严重感染的风险增加有关。我们报告了一例在阿达木单抗上有儿童肺炎和克罗恩病病史的23岁女性中的szulgai分枝杆菌感染病例。
